Avian sarcoma viruses of the A, B, C, D and E subgroups are inactivated about Ioo-fold by the serum of rabbits immunized against chick embryo (CE) cells, in the presence, but not in the absence, of complement. The inactivation is not due to the action of the antiserum and complement on the CE cell cultures used for virus assay, nor to anti-Forssman antibodies, but it is presumably due to antibodies to some antigen(s) common to the surface of CE cells and to the virus envelope. This host cell surface antigen (HSCA) is also present on the surface of the helper viruses RAVI and RAV2 of Bryan strain Rous sarcoma virus. However, it cannot be said whether it is identical for viruses of all subgroups. A parallel electron microscopical study has revealed a characteristic swelling and loss of opacity to electrons of virus particles treated with the antiserum and complement, which appears to precede virolysis.
INTRODUCTION
Chicken leukaemia and sarcoma viruses (ChiLSV) are enveloped viruses released by budding at the cell surface (cf. review by Vogt, I965) . In addition to the virus genomic 7oS RNA, they contain two classes of components: (a) those coded for by the virus, and (b) host cell components.
Components coded for by the virus are, first, the virus internal proteins, some of which are common to all ChiLSV and constitute the virus group-specific (gs) antigens. These correspond to at least 4 distinct polypeptides (cf. Ishizaki, Luftig & Bolognesi, I973). ChiLSV also contain at least 2 glycosylated proteins which correspond to the surface projections of the virus particles and determine the virus envelope (Ve) antigenicity in neutralization tests, interference with viruses of the same antigenicity, and host range of the virus (cf. also Ishizaki et al. I973) . According to these interrelated properties, ChiLSV can be assigned to at least 5 distinct subgroups (A, B, C, D, E) (cf. Hanafusa, Hanafusa & Miyamoto, ~97o) .
Host cell components of viruses are not as well characterized. However, a number have been found, notably minor RNAs and lipids, and it is likely that some antigenic determinants of the virus envelope are of host cell origin (cf. Ishizaki et al. I973) . In favour of I52 M. AUPOIX AND P. VIGIER this view, there is the fact that avian myeloblastosis virus (AMV) carries ATPase on its envelope when it is produced by myeloblasts which also carry ATPase, but not when it is produced by cells which do not carry the enzyme (cf. De Thr, I964). More recently, Ishizaki et al. (I973) have shown that guinea pigs immunized intracerebrally with AMV produced antiserum reacting with intact virus in complement fixation tests. The antigen in question appeared to be located on the surface of virus particles and could be distinguished from the virus type-specific (subgroup) Ve and the gs antigens. It could be isolated and purified by chemical and physical methods, and electron microscopical analysis indicated the presence of a component resembling the outer membrane of the particle. The antigen, designated virus membrane antigen (Vm) was further shown to correspond to a material of about 6ooo daltons containing protein, lipid, and carbohydrate. Serological studies also suggested that the outer membranes of AMV and other ChiLSV are represented mainly by host cell material.
We report here the results of experiments which show, in agreement with these findings, that chicken sarcoma viruses of the A, B, C, D and E subgroups are inactivated to a comparable degree (up to ~oo-fold) by incubation with serum of rabbits immunized with uninfected chick embryo (CE) fibroblasts, when the incubation is carried out in the presence of complement, but not in its absence, or in the presence of complement only. The inactivation is not due to an indirect action of serum and complement on the assay cells, nor to Forssman antigen, and has also been observed after treatment of pelleted virus with trypsin. Electron microscopical studies have further shown a characteristic alteration of virus particles incubated with antiserum and complement which appears to precede virolysis.
On the other hand, no virus inactivation nor alteration of virus particles has been observed following incubation with complement and serum of rabbits immunized against non-permissive hamster cells transformed by RSV and containing both the virus gs antigen(s) and the RSV-specific surface antigen (VISA).
METHODS

Viruses.
The following strains of RSV were used: (a) the clonal strain SR 4 of SchmidtRuppin strain RSV, type D (SR-RSV-D) and its ts mutant FU-I 9 defective for transformation, but not replication at 41 °C (Biquard & Vigier, 1972) All viruses of the A, B, C and D types were produced by transformed cultures of chick embryos from the same line of chicken as the embryos used for preparing cultures for immunizing rabbits, and RSV(o) by cultures of Japanese quail embryos (see below).
Cells and media. Chick embryos (CE) cells used for immunizing rabbits (see below) were from primary cultures of whole embryos from a lymphomatosis-free line of Brown Leghorn fowl (cf. Gold6 & Vigier, 196I) . Although type C particles were never observed in uninfected cultures of these embryos, some were found to contain the virus gs antigen, and, therefore, presumably chf (Vigier & Bataillon, I97I) . The medium for the primary cultures was Eagle's MEM, plus IO % decomplemented calf serum, IO % tryptose phosphate broth (TPB, Difco), and antibiotics (penicillin, streptomycin) .
Secondary cultures of the same CE cells were used for the focus assay of RSV in the (Payne & Chubb, I968) , were also used for the absorption of anti-CE serum (see Results) , and secondary cultures of Japanese quail embryos, which are susceptible to infection with E type viruses, for the assay of RSV(o). The C line embryos were kindly supplied by Dr L. N. Payne (Houghton, Poultry Research Institute) Vigier, 1973 b ). Yet, they contain an appreciable amount of virus gs antigen (Vigier & Bataillon, 1971 ) and carry RSV-specific surface antigen (VISA, or TSSA) (Bataillon, 1973; Aupoix, Simkovic & Gazzolo, 1973) . The culture medium for these cells was the same as for primary CE cells.
Cultures of primary CE cells and RS2/IO cells were carried out in Falcon plastic lO cm dishes of 15o ml T-flasks, and cultures of secondary CE cells for RSV assays in 5 cm Falcon plastic dishes. All cultures were incubated at 37 °C, in a water-saturated air-CO2 atmosphere.
Sera. Immune sera to CE cells (anti-CE) or RS2/xo cells (anti-RS2) were obtained as follows: rabbits were injected intramuscularly with 4 x 207 cells which had been scraped from cultures, washed with PBS and suspended in complete Freund's adjuvant. After 15 days, they were inoculated intravenously with the same number of cells suspended in PBS, and this procedure was repeated three times, at lo-day intervals. The animals were bled 7 days after the last injection, and the sera inactivated at 56 °C for 30 rain.
All inactivated sera were subsequently absorbed with calf serum polymerized in the presence of glutaraldehyde (cf. Avrameas & Ternynck, 1969) , to remove anti-calf serum antibodies due to the presence of calf serum on the cells used for immunization. They were then absorbed with rabbit liver powder to eliminate non-specific immunoglobulins (S. Avrameas, personal communication). In some experiments, anti-CE serum was also absorbed with a homogenate prepared from boiled guinea pig kidney, to remove antiForssman antibodies.
The activity of the immune sera was tested in two ways: (a) by the mixed haemadsorption test, and (b) by the indirect immunofluorescence test. The mixed haemadsorption test was carried out on coverslips seeded sparsely with target cells, as described by Aupoix et al. (1973) . The immunofluorescence test was also carried out on sparsely seeded cells, as follows: the coverslips were washed with PBS and incubated 45 min at 37 °C with the rabbit immune serum, or with normal rabbit serum (controls). They were then washed 3 times for 5 rain with PBS and incubated 30 rain at room temperature with anti-rabbit 7S globulin goat serum labelled with fluorescein isothiocyanate. They were finally washed 3 times with PBS and examined microscopically. The labelled anti-rabbit 7S globulin goat serum was obtained from Hyland's Laboratories, Los Angeles, Calif., U.S.A.
The most potent anti-CE rabbit serum tested was still active at a dilution of lO .o in the mixed haemadsorption test and at a dilution of I "2560 in the indirect immunofluorescence test, whereas the most potent anti-RS2/IO serum was still active at dilutions of lO -5 and I : 1280. Virus inactivation tests. Virus inactivation tests were carried out as follows: virus, i.e. undiluted or diluted medium of RSV-infected cultures containing lO 4 to lO 5 focus forming units (f.f.u.)/ml, was mixed with rabbit anti-CE or anti-RS2flo serum and complement, in the ratio of 9: 1:2 (usually, 0"45 ml of virus, o"o5 ml of serum, and o.I ml of complement), incubated t h at 37 °C, diluted 2o-fold in SM, and assayed for focus formation on secondary cultures of CE cells plated one day before (Vigier, I97o ) . Controls were: (a) virus incubated with the antisera, but without complement; (b) virus incubated with complement, but with normal rabbit serum or MEM instead of the antisera; (c) virus incubated with normal serum and MEM instead of complement, and (d) virus incubated with MEM instead of serum and complement.
Assay cultures were infected for I h at 37 °C and the inoculum was then removed, to avoid an eventual cytotoxic action of anti-CE serum and complement on the assay cells. The infected cultures were overlaid with SM gelled with o'7 % agar (Difco) and incubated at 37 °C. They were re-fed by addition of the same medium (3 ml/dish) 7 days later, and foci scored at 14 days, for B-RSV, or IO days for other viruses.
Electron microscopy studies. Mixtures of virus, serum, and complement, or MEM were incubated as described for inactivation tests, and one drop of each sample was deposited on a grid covered with a carbon membrane evaporated in vacuo. The sample was dried with filter paper, stained with 5 % sodium silicotungstate, dried again, and examined with an AEI-EM6B electron microscope, at 60 kV.
RESULTS
Inactivation of SR-RSV-D by anti-CE serum
Experiments carried out with two different anti-CE rabbit sera gave similar results. As can be seen from Table I , incubation of SR-RSV-D (SR4) with anti-CE rabbit serum (final concentration I : I2) plus complement (final concentration I : 6) reduced the virus titre by 3o-to Ioo-fold, whereas no inactivation was observed after incubation with anti-CE serum or complement alone. No inactivation was observed either following incubation of virus with normal rabbit serum plus complement or with anti-RS2 serum plus complement. Moreover no inactivation was observed when the concentration of anti-RS2 serum was raised fivefold, i.e., to a final proportion of 1:2. 4.
It can further be seen that the ts mutant FU-~9 was inactivated in the same way as SR4, whether it was produced by cells incubated at 37 °C (i.e. transformed) or by cells incubated at 4I °C (i.e. untransformed; Biquard & Vigier, 1972 ) .
Experiments were also performed to rule out the possibility that anti-CE serum and complement may act on the assay CE cells rather than on the virus, as observed earlier by Rubin (I956) . First, it was shown that the virus inactivation was the same when the virus-antiserum-complement mixture was diluted 5oo-fold instead of 2o-fold prior to assay, i.e. when the concentrations of serum and complement in the inoculum were reduced respectively to I : 6ooo and I : 3ooo. As can be seen from Fig. I , virus is not inactivated, and therefore, assay cultures are not affected, when the complement concentration in the standard assay is reduced to I:I5o, i.e. I:3ooo in the inoculum, even though the serum concentration is not reduced. Secondly, CE cell cultures were incubated I h at 37 °C with medium containing the same concentration of anti-CE serum and complement as the diluted virus-antiserum- 
* Virus in culture medium was incubated I h at 37 °C with antiserum (a-CE: anti-chick embryo fibroblasts; a-RS2: anti-RS2/IO cells) and complement, and assayed as described in Methods.
t Relative to control without serum and complement, or to control with anti-CE serum and no complement. In parentheses, focus count in control (mean of 2 replicate assay plates).
:~ Normal rabbit serum. § Antiserum adsorbed with Forssman antigen (see Methods). ]I Virus was pelleted by centrifuging I h at 55 ooo g, following a first centrifuging of the medium containing virus at Ioooo g for IO rain, and the pellet was digested 2o rain at 37 °C with trypsin (Difco, o.I2 ~ in PBS without Ca 2+ and Mg ~+) and resuspended in SM. complement mixture in the standard assay, then washed and infected ~ h with SR 4. The same number of foci was scored in these treated cultures as in untreated controls. Hence, during the period of infection of I h, anti-CE serum and complement present in the inoculum do not impair the capacity of CE cells to become infected and give rise to foci of Rous cells.
These findings suggest that the envelope of SR4 and FU-I9 virus particles carries a host cell surface antigen (HSCA) of normal CE cells, but no surface antigen common to RS2[Io cells and virus-producing CE cells, transformed or untransformed, such as RSVspecific VISA or TSSA.
Inactivation of RS V of other subgroups (types)
Five other RSV strains, belonging respectively to subgroups (A) (SR-RSV-A and B-RSV(RAV I)), B (B-RSV(RAV 2)), C (PR-RSV), and E (RSV(o)) of ChiLSV, behaved in the same way as SR 4 as regards inactivation, or lack of inactivation, following incubation with anti-CE or anti-RS2/~o serum, plus or minus complement (Table 2) of all subgroups presumably carry CE HSCA, but none seems to carry a cell surface antigen common to RS2/Io cells and infected (transformed) CE cells.
Quantitative features of virus inactivation
The inactivation of SR4 in the presence of a complement concentration of I:6 was proportional to the concentration of anti-CE serum in the range of I : I 2 to I : 36oo. At higher dilutions, no inactivation was observed (Fig. I ). Serum concentrations higher than i:I2 did not further inactivate the virus.
On the other hand, in the presence of a serum concentration of I:I2, virus inactivation was proportional to the concentration of complement in the range of 1:6 to I : rSo. Higher concentrations of complement were not tested.
Characterization of the virus-associated CE cell surface antigen
Normal CE cells carrying chf and containing the gs antigen of ChiLSV (gs + h + ceils), but not gs-ceils, generally contain antigen common to that on the envelope of subgroup E viruses (Ve antigen) and located at the cell surface (Hanafusa et al. ~973 
* Same experimental conditions as in Table I .
not inactivate RSV(o) in the absence of complement (cf. Table 2 ). This agrees with the fact that the Brown Leghorn CE cells which were used for immunizing rabbits are only rarely gs + (personal unpublished observation), and presumably carry only low amounts of E type Ve antigen. The possibility remained that HSCA may be a group-specific component of the Ve antigen reacting with antiserum only in the presence of complement. To rule out this possibility, anti-CE antiserum was absorbed with secondary CE cells prepared from embryos of the Reaseheath C line known to be genetically gs-(cf. Methods) and, therefore, presumably devoid of E type Ve antigen. The absorbed serum (pre-diluted t : I5 and incubated with 3 × to8 cells/ml) failed to inactivate significantly SR4, in the presence of complement, whereas unabsorbed control serum (at the same dilution) inactivated the same virus over tenfold. Hence, HSCA responsible for the virus inactivation is present on C line CE cells as well as on Brown Leghorn CE cells, and is presumably not a component of Ve antigen at the cell surface.
The virus-associated HSCA is also not Forssman antigen, since anti-CE serum absorbed with Forssman antigen (see Methods) was shown to inactivate SR4 to the same degree as unabsorbed serum (Table I) Avian tumour virus host cell surface antigen I59 trypsin is inactivated by anti-CE serum plus complement to the same degree as undigested virus (cf . Table I ). Therefore, HSCA is not an adventitious cellular protein adhering to the surface of the virus particles (cf. Discussion).
Electron microscopy studies
As is shown in Fig. 2 , RSV particles incubated with anti-CE serum and complement were markedly altered in comparison with untreated particles; they were generally swollen and no longer opaque to electrons, except for their envelope. They were also generally tailless, in contrast with control virus which often had a tadpole shape. Some images further suggest a process of virolysis. In agreement with the existence of virolysis, preparations of treated virus also contained far fewer virus particles than untreated controls. However, no measurement was carried out. These features were observed for RSV of all subgroups, and were not seen when the virus was incubated with antiserum or complement only, or with anti-RS2 serum and complement.
DISCUSSION
The data presented show that chicken sarcoma viruses belonging to 5 different subgroups (A, B, C, D and E) of ChiLSV all carry an antigen also present on the surface of CE cells before infection. This HSCA is present on non-transforming viruses as well as on transforming viruses, since B-RSV(RAVI) and B-RSV(RAV2) which were inactivated to the same degree as RSV from other strains by anti-CE serum and complement are coated with an envelope borrowed from their non-transforming helper virus (cf. Hanafusa, 1964) .
The virus-associated HSCA is not the Ve antigen of a cryptic virus carried by the CE cells, nor Forssman antigen. It also is presumably not an adventitious host cell surface protein or glycoprotein adhering to the surface of the virus particles, since virus digested with trypsin is inactivated to the same degree as native virus. It could, however, be a glycolipid. It may be noted here that the complement-fixing host cell antigen found in vesicular stomatitis virus (VSV) and believed to be part of the virus surface is also resistant to trypsin (Cartwright & Pearce, I968; Cartwright & Brown, I972) .
Since the Vm antigen found by Ishizaki et al. (1973) was detected by complement fixation and inactivation of RSV by anti-CE serum occurs only in the presence of complement, HSCA and Vm may be the same antigen. This possibility is being tested and the nature of HSCA studied. Our data do not allow us to decide whether HSCA is the same for viruses of all subgroups, or differs with each subgroup.
The electron microscopy studies have shown a marked effect of anti-CE antibody plus complement on the virus particles. The fact that virus particles lose their opacity to electrons suggests that components of the nucleocapsid, in particular RNA, may be lost or degraded. Hence, the alterations observed are presumably a first step towards virolysis. This view is supported by the fact that fewer particles are found in preparations of treated virus than in controls. Virolysis has been observed in the case of MLV treated with antibody to the purified virus plus complement (Orozlan & Gilden, I97O) . In this case, it was shown that the RNA of the virus particles becomes susceptible to RNase digestion and the gs antigen is released. Therefore, we are also studying the fate of the virus RNA and gs antigen in virus particles treated with anti-CE serum plus complement. On the other hand, it may well be that the virolysis of MLV produced by anti-virus serum plus complement is due to antibodies to HSCA present on the virus particles.
Whatever the nature and origin of the virus-associated HSCA, virus inactivation by anti-CE serum and complement can be used for the study of specific problems such as the part Our finding that dilution of the virus-anti-CE serum-complement mixture prior to assay on CE cells does not reverse the virus inactivation contradicts the earlier report of Rubin (I956) that the apparent neutralization of RSV with unheated antiserum to normal chick tissues is completely reversible on dilution of the serum-virus mixture. This discrepancy may be due to differences in experimental conditions, notably as concerns the anti-CE sera, the complement, and the assay systems (focus assay on CE cell monolayers in our experiments and pock assay on the CAM of embryonated eggs in Rubin's experiments).
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